Consolidated Statements of Changes in Mezzanine Equity and Stockholders’ Equity - USD ($)	Total	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023		40,000
Beginning balance at Dec. 31, 2023		$ 39,959,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		11,000
Ending balance at Mar. 31, 2024		$ 39,970,000
Ending balance (in shares) at Mar. 31, 2024	40,000
Beginning balance (in shares) at Dec. 31, 2023			117,372,171
Beginning balance at Dec. 31, 2023	$ 2,748,000		$ 117,000	$ 826,146,000	$ (823,333,000)	$ (182,000)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)			30,640
Stock issued during period, value, stock options exercised (in shares)			15,333
Issuance of common stock pursuant to exercise of stock options	94,000		$ 0	94,000
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			2,099,383
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 2,000	(2,000)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			(77,286)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	(529,000)		$ 0	(529,000)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	18,674,000			18,674,000
Other Comprehensive Income (Loss), Net of Tax	37,000					37,000
Net Income (Loss)	(66,774,000)				(66,774,000)
Ending balance (in shares) at Mar. 31, 2024			119,440,241
Ending balance at Mar. 31, 2024	$ (45,750,000)		$ 119,000	844,383,000	(890,107,000)	(145,000)
Beginning balance (in shares) at Dec. 31, 2024		0
Beginning balance at Dec. 31, 2024		$ 0
Ending balance at Mar. 31, 2025		$ 0
Ending balance (in shares) at Mar. 31, 2025	0
Beginning balance (in shares) at Dec. 31, 2024	126,389,290		126,389,289
Beginning balance at Dec. 31, 2024	$ (82,668,000)		$ 126,000	905,506,000	(988,134,000)	(166,000)
Increase (Decrease) in Stockholders' Equity
Stock issued during period, value, stock options exercised (in shares)	240,865		240,866
Issuance of common stock pursuant to exercise of stock options	$ 1,836,000		$ 1,000	1,835,000
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			1,476,640
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 1,000	(1,000)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			(83,807)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	(721,000)			(721,000)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	16,109,000			16,109,000
Other Comprehensive Income (Loss), Net of Tax	(23,000)					(23,000)
Net Income (Loss)	$ (92,519,000)				(92,519,000)
Ending balance (in shares) at Mar. 31, 2025	128,022,988		128,022,988
Ending balance at Mar. 31, 2025	$ (157,986,000)		$ 128,000	$ 922,728,000	$ (1,080,653,000)	$ (189,000)